FDA Inspection
Carter BloodCareCarter BloodCare – FDA Inspection, Oct 15, 2009
Record Details
This FDA Inspection record concerns Carter BloodCare, with an inspection on October 15, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare
- Inspection Date
- October 15, 2009
- Product Type
- Biologics
View Company Profile
ID · 78d53cfc-2229-41fb-9d3e-5075c73f5b33
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 620063
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | NAI | Center for Biologics Evaluation and Research | |
| January 11, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 2, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare
- FDA Inspection 1272556 - 2025-06-05
- FDA Inspection 1227222 - 2024-01-11
- FDA Inspection 1088131 - 2019-04-05
- FDA Inspection 1029042 - 2017-08-02
- FDA Inspection 871589 - 2014-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.